Ionis to hold fourth quarter and full year 2024 financial results webcast

Webcast scheduled for Wednesday, February 19 at 11:30 a.m. Eastern Time

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, February 19^th at 11:30 a.m. Eastern Time to discuss its fourth quarter and full year 2024 financial results.

The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in innovative late- and mid-stage pipeline across our focus areas of neurology, cardiology and rare diseases. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250205906526/en/